Completed PHASE4 INTERVENTIONAL 2-arm NCT00762164

Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol

Comparative Efficacy of a Vytorin 10/80 Tablet Split Into 4 (Estimated Dose Ezetimibe 2.5 + Simvastatin 20) Versus Simvastatin 20 Milligrams on LDL Cholesterol

Sponsor: Bronx VA Medical Center

Conditions Hypercholesterolemia

Interventions Simvastatin Vytorin

Updated 6 times since 2017 Last updated: Apr 19, 2013 Started: Mar 31, 2007 Primary completion: Apr 30, 2009 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00762164, this PHASE4 trial focuses on Hypercholesterolemia and remains completed. Sponsored by Bronx VA Medical Center, it has been updated 6 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bronx VA Medical Center

Data source: Bronx VA Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• The Bronx, United States